Search Browse Earnings

Aptose Biosciences Inc.

OTC:APTOF

Biological Products, (No Diagnostic Substances)·TORONTO

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

—

Net Income

-$51.2M

FY 2024

EPS (Diluted)

-$227.43

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$9.3M

FY 2024

Total Debt

—

Net Cash

$9.3M

FY 2024

Enterprise Value

—

Debt / EBITDA

—

EV / EBITDA

—

Employees

—